Hospital or health organisation · founded 1904
Fox Chase Cancer Center
Philadelphia, United States · foxchase.org
Part of Temple University Health System
- Citations, last 5 years
- 62.9k
- Works, last 5 years
- 4 126
- h-index
- 738
- Scientists listed
- 0
- Grants since 2016
- 606
Grants received
2019–2024 · research · R01
Novel Role of ThPOK in Mammary Carcinoma
Dietmar J Kappes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel Role of ThPOK in Mammary Carcinoma
Dietmar J Kappes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2020 · research · R01
Cytokine mediated regulation of stress myelopoiesis in abdominal aortic aneurysm
Ekaterina Koltsova · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R03
Novel anti-CD70-VEGF-trap fusion antibodies as a next-generation therapeutic approach for renal cancer
Petr B. Makhov · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R01
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
Stephen Matthew Sykes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel Role of ThPOK in Mammary Carcinoma
Dietmar J Kappes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2020 · research · R01
Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer
Sergei I Grivennikov · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · career development · K99
Defining and targeting the metabolic landscape in Acute Myeloid Leukemia
Daniela Di Marcantonio · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
A New IFN-γ Activated Cell Death Pathway in Salmonella-infected Non-Phagocytic Cells
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R03
The role of cholesterol homeostasis in enzalutamide resistance
Vladimir M Kolenko · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting RIPK3 in Flu-Associated Lung Injury
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2020 · research · R13
African Caribbean Cancer Consortium Scientific and Training Conference
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R03
Enhancing Breast Cancer Clinicians' Communication about Sexual Health: A Mobile Technology-based (mLearning) Intervention
Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Novel Role of ThPOK in Mammary Carcinoma
Dietmar J Kappes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R03
Novel anti-CD70-VEGF-trap fusion antibodies as a next-generation therapeutic approach for renal cancer
Petr B. Makhov · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Novel Role of ThPOK in Mammary Carcinoma
Dietmar J Kappes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R03
Enhancing Breast Cancer Clinicians' Communication about Sexual Health: A Mobile Technology-based (mLearning) Intervention
Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2025 · research · R01
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Targeting asymmetric ciliary signaling in cancer
Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Investigating genetic ancestry influences on oral cavity and laryngeal cancer survival disparities
Camille C. Ragin · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R50
Margret B. Einarson, Ph.D., Manager, High Throughput Screening Facility, Fox Chase Cancer Center
Margret B Einarson · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2021 · research · R21
Targeting asymmetric ciliary signaling in cancer
Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
Stephen Matthew Sykes · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R01
Compensatory mechanisms that promote homologous recombination in BRCA1 mutant cancers
Neil Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2019 · fellowship · F32
Mechanisms of ovary as a site of tumor metastasis rather than origin
Valerie Sodi Salvatico · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2024 · research · R01
Targeting RIPK3 in Flu-Associated Lung Injury
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R03
The role of cholesterol homeostasis in enzalutamide resistance
Vladimir M Kolenko · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R50
Margret B. Einarson, Ph.D., Manager, High Throughput Screening Facility, Fox Chase Cancer Center
Margret B Einarson · Fox Chase Cancer Center · funded by National Institutes of Health
2019–2022 · research · R50
Margret B. Einarson, Ph.D., Manager, High Throughput Screening Facility, Fox Chase Cancer Center
Margret B Einarson · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention
Jennifer Barsky Reese · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants?
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Targeting the Rac1 signaling pathway in malignant melanoma
Jonathan Chernoff · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2020 · research · R01
Targeting Musashi-2 (MSI2) regulation of VEGFR2 / VEGF-A in lung cancer
Yanis Boumber · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2023 · research · R01
Extending a Caribbean Based Cohort to Promote US-Caribbean Comparisons to Facilitate Research Addressing Black Health Disparities
Kimlin Tam Ashing · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2024 · research · R01
Targeting the Rac1 signaling pathway in malignant melanoma
Jonathan Chernoff · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2020 · research · R03
A Plasmid Transfection-Based Method for the Sequential Disruption of Multiple Genes by CRISPR
Hong Yan · Fox Chase Cancer Center · funded by National Institutes of Health
2018–2022 · research · R01
Hepatitis B virus cccDNA
Christoph Seeger · Fox Chase Cancer Center · funded by National Institutes of Health